Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies

The prevalence of benign prostatic hypertrophy (BPH) causing bothersome lower urinary tract symptoms increases with our ageing population. Treatment of BPH traditionally begins with medical therapy and surgical intervention is then considered for those whose symptoms progress despite treatment. Mini...

Full description

Bibliographic Details
Main Authors: Daniel Christidis, Shannon McGrath, Marlon Perera, Todd Manning, Damien Bolton, Nathan Lawrentschuk
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Prostate International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888217300016
_version_ 1797711578345242624
author Daniel Christidis
Shannon McGrath
Marlon Perera
Todd Manning
Damien Bolton
Nathan Lawrentschuk
author_facet Daniel Christidis
Shannon McGrath
Marlon Perera
Todd Manning
Damien Bolton
Nathan Lawrentschuk
author_sort Daniel Christidis
collection DOAJ
description The prevalence of benign prostatic hypertrophy (BPH) causing bothersome lower urinary tract symptoms increases with our ageing population. Treatment of BPH traditionally begins with medical therapy and surgical intervention is then considered for those whose symptoms progress despite treatment. Minimally invasive surgical therapies have been developed as an intermediary in the treatment of BPH with the aim of decreasing the invasiveness of interventions. These therapies also aim to reduce morbidity and dysfunction related to invasive surgical procedures. Multiple treatment options exist in this group including mechanical and thermo-ablative strategies. Emerging therapies utilizing differing technologies range from the established to the experimental. We review the current literature related to these minimally invasive therapies and the evidence of their effectiveness in treating BPH. The role of minimally invasive surgical therapies in the treatment of BPH is still yet to be strongly defined. Given the experimental nature of many of the modalities, further study is required prior to their recommendation as alternatives to invasive surgical therapy. More mature evidence is required for the analysis of durability of effect of these therapies to make robust conclusions of their effectiveness.
first_indexed 2024-03-12T07:09:07Z
format Article
id doaj.art-4a74ba666b2d4965bc684bc652f50949
institution Directory Open Access Journal
issn 2287-8882
language English
last_indexed 2024-03-12T07:09:07Z
publishDate 2017-06-01
publisher Elsevier
record_format Article
series Prostate International
spelling doaj.art-4a74ba666b2d4965bc684bc652f509492023-09-02T23:14:05ZengElsevierProstate International2287-88822017-06-0152414610.1016/j.prnil.2017.01.007Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapiesDaniel Christidis0Shannon McGrath1Marlon Perera2Todd Manning3Damien Bolton4Nathan Lawrentschuk5Department of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaDepartment of Surgery, University of Melbourne, Austin Health, Melbourne, AustraliaThe prevalence of benign prostatic hypertrophy (BPH) causing bothersome lower urinary tract symptoms increases with our ageing population. Treatment of BPH traditionally begins with medical therapy and surgical intervention is then considered for those whose symptoms progress despite treatment. Minimally invasive surgical therapies have been developed as an intermediary in the treatment of BPH with the aim of decreasing the invasiveness of interventions. These therapies also aim to reduce morbidity and dysfunction related to invasive surgical procedures. Multiple treatment options exist in this group including mechanical and thermo-ablative strategies. Emerging therapies utilizing differing technologies range from the established to the experimental. We review the current literature related to these minimally invasive therapies and the evidence of their effectiveness in treating BPH. The role of minimally invasive surgical therapies in the treatment of BPH is still yet to be strongly defined. Given the experimental nature of many of the modalities, further study is required prior to their recommendation as alternatives to invasive surgical therapy. More mature evidence is required for the analysis of durability of effect of these therapies to make robust conclusions of their effectiveness.http://www.sciencedirect.com/science/article/pii/S2287888217300016AquablationBenign prostatic hypertrophyprostatic artery embolizationMinimally invasive surgical therapiesProstatic stenting
spellingShingle Daniel Christidis
Shannon McGrath
Marlon Perera
Todd Manning
Damien Bolton
Nathan Lawrentschuk
Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
Prostate International
Aquablation
Benign prostatic hypertrophyprostatic artery embolization
Minimally invasive surgical therapies
Prostatic stenting
title Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
title_full Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
title_fullStr Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
title_full_unstemmed Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
title_short Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
title_sort minimally invasive surgical therapies for benign prostatic hypertrophy the rise in minimally invasive surgical therapies
topic Aquablation
Benign prostatic hypertrophyprostatic artery embolization
Minimally invasive surgical therapies
Prostatic stenting
url http://www.sciencedirect.com/science/article/pii/S2287888217300016
work_keys_str_mv AT danielchristidis minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies
AT shannonmcgrath minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies
AT marlonperera minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies
AT toddmanning minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies
AT damienbolton minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies
AT nathanlawrentschuk minimallyinvasivesurgicaltherapiesforbenignprostatichypertrophytheriseinminimallyinvasivesurgicaltherapies